Eiger BioPharmaceuticals (EIGR:NSD) Halts Late-Stage Study Following Safety Concerns
Eiger Halts Trial Eiger BioPharmaceuticals Inc, a biotechnology company at the forefront of developing innovative treatments, has made a significant decision to…
Browse research